1,4-bis(2-(3,5-dichloropyridyloxy))benzene has been researched along with Liver Dysfunction in 1 studies
1,4-bis(2-(3,5-dichloropyridyloxy))benzene: potent phenobarbital-like inducer of microsomal monooxygenase activity; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baskin-Bey, ES | 1 |
| Huang, W | 1 |
| Ishimura, N | 1 |
| Isomoto, H | 1 |
| Bronk, SF | 1 |
| Braley, K | 1 |
| Craig, RW | 1 |
| Moore, DD | 1 |
| Gores, GJ | 1 |
1 other study available for 1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Liver Dysfunction
| Article | Year |
|---|---|
Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins.
Topics: Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Chemical | 2006 |